Lifevantage/LFVN

$6.70

0.6%
-
1D1W1MYTD1YMAX

About Lifevantage

LifeVantage Corporation is engaged in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. The Company's dietary supplements include its flagship Protandim family of products, LifeVantage Omega+, ProBio, IC Bright, and Daily Wellness dietary supplements. The Protandim product line includes Protandim NRF1 Synergizer, Protandim Nrf2 Synergizer, and Protandim NAD Synergizer. TrueScience is its line of skin, hair, bath and body, and targeted relief products. The Company also markets and sells Petandim, its companion pet supplement formulated to combat oxidative stress in dogs; Axio, its nootropic energy drink mixes, and PhysIQ, its smartweight management system, which includes PhysIQ Fat Burn and PhysIQ Prebiotic, all formulated to aid in weight management.

Ticker

LFVN

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Steven Fife

Employees

248

Headquarters

Lehi, United States

Lifevantage Metrics

BasicAdvanced
$84.93M
Market cap
28.47
P/E ratio
$0.23
EPS
0.78
Beta
$0.14
Dividend rate
2.12%
Dividend yield
$84.93M
0.78452
$8.69
$2.88
35.46K
$0.14
1.68
1.029
230.23%
4.54%
10%
7.04%
28.465
0.403
3.113
3.155
22.758
2.05%
2.12%
2.21%
431.89%
-2.88%
-36.55%

Lifevantage Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1.16% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$51.6M
0.58%
Net income
$-600K
-200%
Profit margin
-1.16%
-200%

Lifevantage Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 150%
QuarterlyAnnual
Q2 24
Q3 24
Actual
$0.10
-
Expected
$0.04
$0.16
Surprise
150%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Lifevantage stock?

Lifevantage (LFVN) has a market cap of $85.7M as of April 20, 2024.

What is the P/E ratio for Lifevantage stock?

The price to earnings (P/E) ratio for Lifevantage (LFVN) stock is 28.72 as of April 20, 2024.

Does Lifevantage stock pay dividends?

Yes, the Lifevantage (LFVN) stock pays dividends to shareholders. As of April 20, 2024, the dividend rate is $0.135 and the yield is 2.1%. Lifevantage has a payout ratio of 230.23% on a trailing twelve-month basis.

When is the next Lifevantage dividend payment date?

The next Lifevantage (LFVN) dividend payment date is unconfirmed.

What is the beta indicator for Lifevantage?

Lifevantage (LFVN) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Lifevantage stock price target?

The target price for Lifevantage (LFVN) stock is $, which is 100% below the current price of $6.7. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Lifevantage stock

Buy or sell Lifevantage stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing